Back to Search Start Over

Intervention effectiveness by pharmacists integrated within an interdisciplinary health team on chronic complex patients.

Authors :
Acosta-García, Hector
Alfaro-Lara, Eva Rocío
Sánchez-Fidalgo, Susana
Sevilla-Sánchez, Daniel
Delgado-Silveira, Eva
Juanes-Borrego, Ana
Santos-Ramos, Bernardo
Source :
European Journal of Public Health; Oct2020, Vol. 30 Issue 5, p886-899, 14p
Publication Year :
2020

Abstract

Background Nowadays, it is difficult to establish a specific method of intervention by the pharmacist and its clinical repercussions. Our aim was to identify interventions by pharmacists integrated within an interdisciplinary team for chronic complex patients (CCPs) and determine which of them produce the best results. Methods A systematic review (SR) was performed based on PICO(d) question (2008–18): (Population): CCPs; (Intervention): carried out by health system pharmacists in collaboration with an interdisciplinary team; (Comparator): any; (Outcome): clinical and health resources usage outcomes; (Design): meta-analysis, SR and randomized clinical trials. Results Nine articles were included: one SR and eight randomized clinical trials. The interventions consisted mainly in putting in order the pharmacotherapy and the review of the medication adequacy, medication reconciliation in transition of care and educational intervention for health professionals. Only one showed significant improvements in mortality (27.9% vs. 38.5%; HR = 1.49; P  = 0.026), two in health-related quality of life [according to EQ-5D (European Quality of Life—5 Dimensions) and EQ-VAS (European Quality of Life—Visual Analog Scale) tests] and four in other health-related results (subjective self-assessment scales, falls or episodes of delirium and negative health outcomes associated with medication). Significant differences between groups were found in hospital stay and frequency of visits to the emergency department. No better results were observed in hospitalization rate. Otherwise, one study measured cost utility and found a cost of €45 987 per quality-adjusted life year gained due to the intervention. Conclusions It was not possible to determine with certainty which interventions produce the best results in CCPs. The clinical heterogeneity of the studies and the short follow-up of most studies probably contributed to this uncertainty. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11011262
Volume :
30
Issue :
5
Database :
Complementary Index
Journal :
European Journal of Public Health
Publication Type :
Academic Journal
Accession number :
146347533
Full Text :
https://doi.org/10.1093/eurpub/ckz224